Opioid addiction implant maker Braeburn Pharma pulls IPO

(Reuters) – Braeburn Pharmaceuticals Inc, the maker of the first long-acting implant to treat opioid addiction in the United States, said on Thursday that it had decided not to proceed with its…

Leave a Reply

Read the original at Reuters: Deals.